ClinicalTrials.Veeva

Menu

Altered PSA Test Due to Possible Suspected Heterophilic Antibodies

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Terminated

Conditions

PSA

Study type

Observational

Funder types

Other

Identifiers

NCT02455466
2014-0652

Details and patient eligibility

About

The purpose of this study is to investigate if clinically non explainable high or low Prostate-specific antigen (PSA) levels are associated with heterophilic antibodies in the serum of participants. The investigators will examine if heterophilic antibodies are the reasons of altered PSA levels.

Enrollment

50 patients

Sex

Male

Ages

40 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male, with a a clinically high or low unexplainable PSA measurement
  • Age between 40 and 90 years
  • Written informed consent

Exclusion criteria

  • Female
  • No PSA measurement available or planned
  • Age over 90 or under 40 years

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems